The soft-tissue and recovery branch of the research-peptide literature is dominated by three compounds: BPC-157, TB-500, and GHK-Cu. They appear together constantly — in forums, supplier bundles, and preclinical protocols — but they act through different mechanisms, which is what determines how a research model uses them. This guide compares all three. Everything below concerns laboratory and in-vitro research only — not medical guidance, and not for human or veterinary use.
The three compounds, by mechanism
- BPC-157 — a pentadecapeptide (“Body Protection Compound”) studied in angiogenesis and tissue-repair signaling across gut, tendon, and other models.
- TB-500 — a synthetic fragment related to Thymosin Beta-4, studied in actin regulation, cell migration, and tissue remodeling.
- GHK-Cu — a copper-binding tripeptide studied in skin remodeling, collagen, and wound-research models.
Compound-by-compound
BPC-157 — tissue-protection signaling
BPC-157 is a 15-amino-acid peptide derived from a gastric protein. The research literature focuses on its role in angiogenesis (new blood-vessel formation) and tissue-repair pathways, studied across a range of soft-tissue models. It is the most-cited of the three. Available as 5mg and 10mg research vials.
TB-500 — actin regulation and cell migration
TB-500 is a synthetic fragment associated with Thymosin Beta-4, studied for its role in actin sequestration, cell migration, and tissue remodeling. Its mechanism is distinct from BPC-157’s, which is why the two are frequently studied as a pair rather than as substitutes.
GHK-Cu — copper-peptide skin and collagen research
GHK-Cu is a copper-binding tripeptide studied primarily in skin-remodeling, collagen-synthesis, and wound-research contexts. The copper complex is integral to its studied activity, distinguishing it mechanistically from the other two.
Comparison at a glance
| Compound | Type | Primary research pathway |
|---|---|---|
| BPC-157 | Pentadecapeptide | Angiogenesis / tissue-repair signaling |
| TB-500 | Thymosin β4 fragment | Actin regulation / cell migration |
| GHK-Cu | Copper tripeptide | Skin remodeling / collagen |
Why BPC-157 and TB-500 are studied together
BPC-157 and TB-500 act through complementary tissue-repair mechanisms, which is why “the stack” is such a recurring design in the recovery literature. We cover that specific pairing in depth — mechanism, what the research says, and handling — in the BPC-157 + TB-500 stack research guide. GHK-Cu is sometimes added as a third element where skin/collagen endpoints are also part of the model.
How researchers choose
- Angiogenesis / general soft-tissue repair signaling? BPC-157.
- Actin dynamics / cell migration / remodeling? TB-500.
- Skin, collagen, wound-research endpoints? GHK-Cu.
- Complementary repair pathways together? BPC-157 + TB-500 (see the stack guide).
Research handling & verification
All ship as lyophilized powder, reconstituted with bacteriostatic water (see the reconstitution guide). Confirm identity and purity on an independent third-party COA before use; Bastion’s recovery-class compounds are Janoshik-verified per lot, with figures in the public purity report (including the GLOW blend that combines BPC-157 and TB-500, composition-confirmed by mass).
Frequently asked questions
What is the difference between BPC-157 and TB-500?
They act through different mechanisms. BPC-157 is studied in angiogenesis and tissue-protection signaling; TB-500 (a Thymosin Beta-4 fragment) is studied in actin regulation and cell migration. They are complementary, which is why they’re often paired.
What is GHK-Cu used for in research?
GHK-Cu, a copper-binding tripeptide, is studied primarily in skin-remodeling, collagen-synthesis, and wound-research models.
Why are these three compounds grouped together?
All three are studied in soft-tissue and recovery research, but through distinct mechanisms — which is why they’re combined in models examining multiple repair pathways rather than used interchangeably.
Are these compounds approved for human use?
No. They are supplied strictly as research compounds for in-vitro and laboratory study, not for human or veterinary use.
How do I verify the purity of these peptides?
Use an independent third-party COA (HPLC purity + mass-spec identity) tied to the specific batch and verifiable on the testing lab’s own database.
Bastion’s recovery-class catalog
- BPC-157 5mg / 10mg — tissue-repair signaling
- TB-500 5mg — actin / cell migration
- GHK-Cu 50mg — copper-peptide skin/collagen research
All supplied as lyophilized research vials with independent Janoshik COAs and free customs reship to the USA and Canada.
For research use only. Bastion Peptides supplies compounds intended for laboratory and in-vitro research. Not for human or veterinary consumption. The above summarizes research-literature context and is not medical advice.